Diallo I, Husseini Z, Guellal S, Vion E, Ho J, Kozak R
Int J Mol Sci. 2022; 23(9).
PMID: 35563619
PMC: 9106010.
DOI: 10.3390/ijms23095228.
Sirmarova J, Salat J, Palus M, Honig V, Langhansova H, Holbrook M
Emerg Microbes Infect. 2018; 7(1):175.
PMID: 30401896
PMC: 6220120.
DOI: 10.1038/s41426-018-0177-z.
Lavender K, Williamson B, Saturday G, Martellaro C, Griffin A, Hasenkrug K
J Infect Dis. 2018; 218(suppl_5):S409-S417.
PMID: 30085162
PMC: 6249575.
DOI: 10.1093/infdis/jiy269.
Spengler J, Prescott J, Feldmann H, Spiropoulou C
Curr Opin Virol. 2017; 25:90-96.
PMID: 28810165
PMC: 5610641.
DOI: 10.1016/j.coviro.2017.07.028.
Spengler J, Lavender K, Martellaro C, Carmody A, Kurth A, Keck J
J Infect Dis. 2016; 214(suppl 3):S308-S318.
PMID: 27601621
PMC: 5050473.
DOI: 10.1093/infdis/jiw248.
Immunological features underlying viral hemorrhagic fevers.
Messaoudi I, Basler C
Curr Opin Immunol. 2015; 36:38-46.
PMID: 26163194
PMC: 4593727.
DOI: 10.1016/j.coi.2015.06.003.
Ebola virus outbreak, updates on current therapeutic strategies.
Elshabrawy H, Erickson T, Prabhakar B
Rev Med Virol. 2015; 25(4):241-53.
PMID: 25962887
PMC: 7169053.
DOI: 10.1002/rmv.1841.
Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes.
Kindrachuk J, Wahl-Jensen V, Safronetz D, Trost B, Hoenen T, Arsenault R
J Virol. 2014; 88(17):9877-92.
PMID: 24942569
PMC: 4136307.
DOI: 10.1128/JVI.01410-14.
Filovirus entry.
Simmons G
Adv Exp Med Biol. 2013; 790:83-94.
PMID: 23884587
PMC: 7114988.
DOI: 10.1007/978-1-4614-7651-1_5.
Ebola virus exploits a monocyte differentiation program to promote its entry.
Martinez O, Johnson J, Honko A, Yen B, Shabman R, Hensley L
J Virol. 2013; 87(7):3801-14.
PMID: 23345511
PMC: 3624207.
DOI: 10.1128/JVI.02695-12.
Shedding light on filovirus infection with high-content imaging.
Pegoraro G, Bavari S, Panchal R
Viruses. 2012; 4(8):1354-71.
PMID: 23012631
PMC: 3446768.
DOI: 10.3390/v4081354.
Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.
Zapata J, Pauza C, Djavani M, Rodas J, Moshkoff D, Bryant J
Antiviral Res. 2011; 92(2):125-38.
PMID: 21820469
PMC: 3209703.
DOI: 10.1016/j.antiviral.2011.07.015.
Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.
Cilloniz C, Ebihara H, Ni C, Neumann G, Korth M, Kelly S
J Virol. 2011; 85(17):9060-8.
PMID: 21734050
PMC: 3165855.
DOI: 10.1128/JVI.00659-11.
C-type lectins do not act as functional receptors for filovirus entry into cells.
Matsuno K, Nakayama E, Noyori O, Marzi A, Ebihara H, Irimura T
Biochem Biophys Res Commun. 2010; 403(1):144-8.
PMID: 21056544
PMC: 3393133.
DOI: 10.1016/j.bbrc.2010.10.136.
Different potential of C-type lectin-mediated entry between Marburg virus strains.
Matsuno K, Kishida N, Usami K, Igarashi M, Yoshida R, Nakayama E
J Virol. 2010; 84(10):5140-7.
PMID: 20219911
PMC: 2863822.
DOI: 10.1128/JVI.02021-09.
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.
Oswald W, Geisbert T, Davis K, Geisbert J, Sullivan N, Jahrling P
PLoS Pathog. 2007; 3(1):e9.
PMID: 17238286
PMC: 1779296.
DOI: 10.1371/journal.ppat.0030009.
Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence.
Kash J, Muhlberger E, Carter V, Grosch M, Perwitasari O, Proll S
J Virol. 2006; 80(6):3009-20.
PMID: 16501110
PMC: 1395418.
DOI: 10.1128/JVI.80.6.3009-3020.2006.
DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.
Marzi A, Gramberg T, Simmons G, Moller P, Rennekamp A, Krumbiegel M
J Virol. 2004; 78(21):12090-5.
PMID: 15479853
PMC: 523257.
DOI: 10.1128/JVI.78.21.12090-12095.2004.
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry.
Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, Ebihara H
J Virol. 2004; 78(6):2943-7.
PMID: 14990712
PMC: 353724.
DOI: 10.1128/jvi.78.6.2943-2947.2004.
Antibody-dependent enhancement of Ebola virus infection.
Takada A, Feldmann H, Ksiazek T, Kawaoka Y
J Virol. 2003; 77(13):7539-44.
PMID: 12805454
PMC: 164833.
DOI: 10.1128/jvi.77.13.7539-7544.2003.
